Poor-quality antimalarial drugs lead to drug resistance and inadequate treatment, which
pose an urgent threat to vulnerable populations and jeopardise progress and investments in …

Background There are concerns about the quality of medicines available in low-and middle-
income countries (LMIC) to manage hemorrhage, pre-eclampsia/eclampsia and sepsis. We …

Introduction Quality of medicines in both developed and developing countries is sometimes
compromised due to infiltration of counterfeit, substandard or degraded medicines into the …

Technological capabilities that are necessary for industrial development are often learned
from others. But where does technology come from and through which channels? This …

The quality of essential medicines for pediatric populations in developing countries is largely
unknown. This review examines quality studies (2000–2011) of medicines on the WHO …

Background The use of poor quality drugs will have multiple consequences with an
extended hazard of growing drug-resistant strains. Purpose The review aimed to provide the …

Background The ineffectiveness of artesunate and amodiaquine tablets in malaria treatment
remains a health burden to WHO and governments of malaria-endemic countries, including …

Abstract During the period 2011-2015, the Drug Analysis and Research Unit (DARU)
analyzed 1972 drug samples. The samples consisted of 21.5% locally manufactured and …

This article investigates the nature and potential trajectories of global disputes. Conventional
accounts of global disputes often see them as inherently open-ended so that actors can …

Abstract During the period 2006-2010, the Drug Analysis and Research Unit analyzed 583
samples. The samples comprised 50.6% local and 49.4% imported products. Samples were …